PRG's 22.3% gain over the last year—against a declining broader market—demonstrates its capacity to deliver strong absolute returns and defensive upside during macro‑downturns, bolstering its appeal for risk‑averse growth investors.
The five‑year annualized decline of -7.1%, though better than the S&P, indicates that periods of contract lag or budgetary cuts can erode returns; a sustained reduction in defense appropriations could push PRG's long‑term CAGR below its historical +3% benchmark.
The -1.09% institutional outflow, while small, combined with the high beta could exacerbate downside risk if market sentiment turns sharply, potentially triggering a faster-than-average sell‑off as leveraged institutional holders cut exposure.
The combination of negative revenue CAGR (–2.5%) and zero R&D spend highlights a structural weakness: the firm is not reinvesting to reverse its decline, making the current earnings trajectory unsustainable for investors seeking growth.
The net margin of 6.1% translates to roughly $146 M of profit on $2.4 B sales; a further 1% drop in margin would shave $24 M from earnings, tightening cash flow and potentially triggering covenant breaches if revenue continues to fall.
Margin growth is the standout driver, lifting profitability by 1.8 percentage points and underpinning the near‑doubling of ROE, which signals strong pricing power or cost discipline that can sustain higher returns to equity.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2025 | 19.7 | 6.1 | 1.50 | 2.16 | 17.5 | 15.7 | 9.1 |
| 2024 | 30.3 | 8.0 | 1.63 | 2.33 | 15.1 | 14.6 | 13.0 |
| 2023 | 23.5 | 5.8 | 1.61 | 2.52 | 18.0 | 16.8 | 9.3 |
| 2022 | 17.3 | 3.8 | 1.74 | 2.62 | 14.4 | 13.7 | 6.6 |
| 2021 | 35.8 | 9.1 | 1.65 | 2.39 | 23.5 | 22.4 | 15.0 |
| 2020 | -6.2 | -2.5 | 1.89 | 1.34 | 22.7 | 21.9 | -4.7 |
| 2019 | 1.8 | 1.5 | 0.66 | 1.90 | 2.4 | 0.9 | 1.0 |
| 2018 | 11.1 | 5.1 | 1.35 | 1.61 | 12.3 | 12.1 | 6.9 |
| 2017 | 16.9 | 8.6 | 1.26 | 1.56 | 11.6 | 11.3 | 10.9 |
| 2016 | 9.4 | 4.3 | 1.23 | 1.77 | 11.6 | 11.3 | 5.3 |
| 2015 | 9.9 | 4.3 | 1.20 | 1.95 | 10.7 | 10.6 | 5.1 |
The 158‑day cash conversion cycle represents a liquidity risk; if collections slow or inventory levels rise further, free cash flow could be pressured by up to $50 million annually, potentially constraining dividend sustainability or growth initiatives.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2025 | 244 | 138 | 25 | 3 | 4 | 158 |
| 2024 | 224 | 0 | 35 | 4 | 0 | 35 |
| 2023 | 226 | 147 | 30 | 5 | 5 | 172 |
| 2022 | 210 | 0 | 27 | 5 | 0 | 27 |
| 2021 | 221 | 143 | 25 | 6 | 3 | 166 |
| 2020 | 194 | 132 | 21 | 7 | 2 | 150 |
| 2019 | 556 | 165 | 24 | 9 | 3 | 186 |
| 2018 | 269 | 2481 | 17 | 22 | 166 | 2331 |
| 2017 | 290 | 1624 | 20 | 22 | 114 | 1530 |
| 2016 | 298 | 1236 | 21 | 24 | 89 | 1167 |
| 2015 | 305 | 1115 | 23 | 26 | 97 | 1041 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2025 | $1610M | $864M | $746M | $609M | $301M | $309M | $1083M | $96M |
| 2024 | $1514M | $863M | $650M | $655M | $559M | $96M | $1075M | $181M |
| 2023 | $1491M | $900M | $591M | $608M | $453M | $155M | $984M | $151M |
| 2022 | $1492M | $921M | $570M | $612M | $480M | $132M | $975M | $135M |
| 2021 | $1622M | $942M | $679M | $615M | $445M | $170M | $1070M | $136M |
| 2020 | $1317M | $331M | $986M | $80M | $43M | $37M | $787M | $78M |
| 2019 | $3298M | $1561M | $1737M | $34M | $-24M | $58M | $852M | $234M |
| 2018 | $2827M | $1066M | $1761M | $425M | $409M | $15M | $1603M | $430M |
| 2017 | $2687M | $959M | $1728M | $369M | $318M | $51M | $1568M | $440M |
| 2016 | $2616M | $1134M | $1482M | $498M | $189M | $309M | $1585M | $475M |
| 2015 | $2659M | $1292M | $1367M | $610M | $596M | $15M | $1595M | $425M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $335M | $7M | $-128M | $-10M | $325M | $-52M | $-21M |
| 2024 | $139M | $-79M | $-119M | $-8M | $130M | $-139M | $-20M |
| 2023 | $204M | $-39M | $-142M | $-10M | $195M | $-140M | |
| 2022 | $242M | $-54M | $-227M | $-10M | $233M | $-224M | |
| 2021 | $246M | $-82M | $-30M | $-10M | $236M | $-571M | |
| 2020 | $456M | $-115M | $-363M | $-64M | $392M | $-14M | |
| 2019 | $317M | $-106M | $-169M | $-93M | $224M | $-69M | $-9M |
| 2018 | $356M | $-263M | $-129M | $-79M | $278M | $-169M | $-6M |
| 2017 | $158M | $-204M | $-211M | $-58M | $100M | $-63M | $-8M |
| 2016 | $465M | $-20M | $-152M | $-57M | $408M | $-35M | $-7M |
| 2015 | $167M | $-109M | $-47M | $-61M | $106M | $-0M | $-7M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net